{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-123677","form_type":"8-K/A","ticker":null,"cik":"0001496323","company_name":"IGM Biosciences, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.586850+00:00","generated_at":"2026-05-30T02:46:39.171319+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"IGM Biosciences estimates $11.7M-$14.4M in restructuring charges for strategic pivot","bullets":["Total restructuring charges estimated between $11.7M and $14.4M.","Cash costs: $3.4M to $5.7M for severance and termination; $0.1M to $0.3M for contract termination.","Non-cash stock-based compensation: $8.2M to $8.4M.","Substantially all charges expected in Q3 2024; restructuring complete by Q2 2025.","Amends Oct 3, 2024 8-K disclosing shift away from aplitabart and oncology R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-123677","json":"https://secwatch.observer/filing/0000950170-24-123677.json","markdown":"https://secwatch.observer/filing/0000950170-24-123677.md","text":"https://secwatch.observer/filing/0000950170-24-123677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496323/000095017024123677/0000950170-24-123677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496323/000095017024123677/igms-20240927.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:46:39.171319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81739af0bdedfd6004795f240768d533afe1d0f1","claim":"IGM Biosciences, Inc. announced a restructuring with charges of total restructuring charges between $11.7 million and $14.4 million.","evidence_excerpt":"As a result of the 2024 Restructuring, the Company estimates it will incur total restructuring charges between $11.7 million and $14.4 million","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1496323/000095017024123677/0000950170-24-123677-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"total restructuring charges between $11.7 million and $14.4 million"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}